Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes

References

• Asanuma M, Hayashi T, Ordonez SV, Ogawa N, Cadet JL (2000). Direct interactions of methamphetamine with the nucleus. Brain Res Mol Brain Res 80: 237–243.
   PubMedGoogle Scholar
• Bagasra O, Pomerantz RJ (1993a). Human immunodefi-ciency virus type I provirus is demonstrated in periph-eral blood monocytes in vivo: a study utilizing an in situ polymerase chain reaction. AIDS Res Hum Retroviruses 9: 69–76.
   Google Scholar
• Bagasra O, Pomerantz RJ (1993b). The role of CD8-positive lymphocytes in the control of HIV-1 infection of pe-ripheral blood mononuclear cells. Immunol Lett 35: 83–92.
   PubMed Web of Science ®Google Scholar
• Belman AL (1994). HIV-1-associated CNS disease in infants and children. Res Pub] Assoc Res Nerv Ment Dis 72: 289–310.
   Google Scholar
• Billaud JN, Selway D, Yu N, Phillips TR (2000). Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: implications for glutamate uptake. Virology 266: 180–188.
   Google Scholar
• Blumberg BM, Gelbard HA, Epstein LG (1994). HIV-1 in-fection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res 32: 253–267.
   PubMed Web of Science ®Google Scholar
• Boutet A, Salim H, Taoufik Y, Lledo PM, Vincent JD, Delfraissy JF, Tardieu M (2001). Isolated human astro-cytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Glia 34: 165–177.
   Google Scholar
• Brack-Werner R (1999a). Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis . AIDS 13: 1–22.
   PubMed Web of Science ®Google Scholar
• Brack-Werner R (1999b). Replication of HIV-1 in human astrocytes. NeuroAIDS 2: www.sciencemag.org/NAIDS.
   Google Scholar
• Cadet JL, Jayanthi S, McCoy MT, Vawter M, Ladenheim B (2001). Temporal profiling of methamphetamine - induced changes in gene expression in the mouse brain: evidence from cDNA array. Synapse 41: 40–48.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control (1995). Increasing mor-bidity and mortality associated with abuse of methamphetamine-United States, 1991-1994. MIVIWR Morb Mort Wkly Rep 44: 882–886.
   PubMedGoogle Scholar
• Chapman DE, Hanson GR, Kesner RP, Keefe KA (2001). Long-term changes in basal ganglia function after a neu-rotoxic regimen of methamphetamine. J Pharmacol Exp Ther 296: 520–527.
   PubMed Web of Science ®Google Scholar
• Cole SW, Jamieson BD, Zack JA (1999). cAMP up-regulates cell surface expression of lymphocyte CXCR4: impli-cations for chemotaxis and HIV-1 infection. I Immunol 162: 1392–1400.
   PubMed Web of Science ®Google Scholar
• Cole SW, Korin YD, Fahey JL, Zack JA (1998). Nore-pinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 161: 610–616.
   PubMed Web of Science ®Google Scholar
• Cubells JF, Rayport S, Rajendran G, Sulzer D (1994). Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependen t intra-cellular oxidative stress. J Neurosci 14: 2260–2271.
   Google Scholar
• de Parseval A, Elder JH (2001). Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol 75: 4528–4539.
   PubMed Web of Science ®Google Scholar
• Dow SW, Dreitz MJ, Hoover EA (1992). Feline immuno-deficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Vet Immunol Immunopathol 35: 23–35.
   Google Scholar
• Driscoll RC, Barr FS, Gragg BJ, Moore GW (1971). Determi-nation of therapeutic blood levels of methamphetamine and pentobarbital by GC. J Pharm Sci 60: 1492–1495.
   PubMed Web of Science ®Google Scholar
• Ellison G, Switzer RC (1993). Dissimilar patterns of degen-eration in brain following four different addictive stim-ulants. Neuroreport 5: 17–20.
   PubMed Web of Science ®Google Scholar
• Epstein LG, Gelbard HA (1999). HIV-1-induced neuronal injury in the developing brain. I Leukoc Biol 65: 453–457.
   PubMed Web of Science ®Google Scholar
• Gavrilin MA, Deucher MF, Boeckman F, Kolattukudy PE (2000). Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes. Biochem Bio-phys Res Commun 277: 37–42.
   Google Scholar
• Glass JD, Johnson RT (1996). Human immunodeficiency virus and the brain. Annu Rev Neurosci 19: 1-26. Gorman M (1996). Speed use and HIV transmission. Focus 11: 4–6.
   Google Scholar
• Gruol DL, Yu N, Parsons KL, Billaud JN, Elder JH, Phillips TR (1998). Neurotoxic effects of feline im-munodeficiency virus, FIV-PPR. I NeuroVirol 4: 415–425.
   PubMed Web of Science ®Google Scholar
• Hohdatsu T, Hirabayashi H, Motokawa K, Koyama H (1996). Comparative study of the cell tropism of feline immun-odeficiency virus isolates of subtypes A, B and D classi-fied on the basis of the env gene V3-V5 sequence. I Gen Virol 77: 93–100.
   Google Scholar
• House RV, Thomas PT, Bhargava HN (1994). Compar-ison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol 16: 1–21.
   PubMed Web of Science ®Google Scholar
• Kaul M, Garden GA, Lipton SA (2001). Pathways to neu-ronal injury and apoptosis in HIV-associated dementia. Nature 410: 988–994.
   PubMed Web of Science ®Google Scholar
• Koirala TR, Sharma S, Morikawa S, Ishida T (2000). Expres-sion of CXCR4 in the brain of feline immunodeficiency virus infected cat. Indian I Pathol Microbiol 43: 285–290.
   Google Scholar
• Kolchinsky P, Mirzabekov T, Farzan M, Kiprilov E, Cayabyab M, Mooney LJ, Choe H, Sodroski J (1999). Adaptation of a CCR5-using, primary human immun-odeficiency virus type 1 isolate for CD4-independent replication. I Virol 73: 8120–8126.
   PubMed Web of Science ®Google Scholar
• Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B (1998). Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. JBiomed Sci 5: 31–44.
   Google Scholar
• Lerner DL, Elder JH (2000). Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells. I Virol 74: 1854–1863.
   Google Scholar
• Levine MS, Hull CD, Garcia-Rill E, Erinoff L, Buchwald NA, Heller A (1980). Long-term decreases in spontaneous fir-ing of caudate neurons induced by amphetamine in cats. Brain Res 194: 263–268.
   Google Scholar
• Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson PJ, Cihak J, Plachy J, Stangassinge M, Erfle V, Schlondorff D (2000). Transfer of the chemokine receptor CCR5 between cells by membrane-derived mi-croparticles: a mechanism for cellular human immuno-deficiency virus 1 infection. Nat Med 6: 769–775.
   Google Scholar
• McArthur J, Grant 1(1998). HIV Neurocognitive Disorders. In: The Neurology of AIDS. Gendelman HE, Lipton SA, Epstein L, Swindells S (eds). New York, Chapman & Hall, pp 499–523.
   Google Scholar
• McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM, Tong J, Schmunk G, Adams V, Kish SJ (2000). The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. J Neurochem 74: 2120–2126.
   Google Scholar
• Nakagaki K, Nakagaki K, Takahashi K, Schols D, de Clercq E, Tabira T (2001). CXCR4 is the primary receptor for fe-line immunodeficiency virus in astrocytes. J NeuroVirol 7: 487–492.
   Google Scholar
• Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR (2001). Acceleration of HIV dementia with metham-phetamine and cocaine. J NeuroVirol 7: 66–71.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Gekker G, Schut R, Hu S, Balfour HH Jr, Chao CC (1993). Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv Exp Med Biol 335: 181–188.
   Google Scholar
• Phillips TR, Billaud JN, Henriksen SJ (2000). Metham-phetamine and HIV-1: potential interactions and the use of the FIV/cat model. J Psychopharmacol 14: 244–250.
   Google Scholar
• Podell M, Oglesbee M, Mathes L, Krakowka S, Olmstead R, Lafrado L (1993). AIDS-associated en-cephalopathy with experimental feline immunodefi-ciency virus infection. I Acquir Immune Defic Syndr 6: 758–771.
   Google Scholar
• Podell M, Hayes K, Oglesbee M, Mathes L (1997). Progres-sive encephalopathy associated with CD4/CD8 inver-sion in adult FIV-infected cats. I Acquir Immune Defic Syndr Hum Retrovirol 15: 332–340.
   Google Scholar
• Podell M, March PA, Buck WR, Mathes LE (2000). The fe-line model of neuroAIDS: understanding the progres-sion towards AIDS dementia. I Psychopharmacol 14: 205–213.
   Google Scholar
• Podell M, Maruyama K, Smith M, Hayes KA, Buck WR, Ruehlmann DS, Mathes LE (1999). Frontal lobe neuronal injury correlates to altered function in Fly- infected cats. J Acquir Immune Defic Syndr 22: 10–18.
   Google Scholar
• Podell M, Buck WR, Hayes KA, Gavrilin MA, Mathes LE (2001). Animal models of retroviral encephalopathies : Feline model. In: Current Protocols in Neuroscience. Crawley JN, Gerfen CR, Rogawski MA, Sibley DR, Skolnick P, Wray S (eds). New York, John Wiley & Sons, Suppl 17: 9.9.1–9.9.30.
   Google Scholar
• Reeves JD, Hibbitts S, Simmons G, McKnight A, Azevedo - Pereira JM, Moniz-Pereira, Clapham PR (1999). Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: com-parison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. I Virol 73: 7795–7804.
   Google Scholar
• Richardson J, Pancino G, Merat R, Leste-Lasserre T, Moraillon A, Schneider-Mergener J, Alizon M, Sonigo P, Heveker N (1999). Shared usage of the chemokine recep-tor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. I Virol 73: 3661–3671.
   Google Scholar
• Schmued LC, Bowyer JF (1997). Methamphetamine expo-sure can produce neuronal degeneration in mouse hip-pocampal remnants. Brain Res 759: 135–140.
   PubMed Web of Science ®Google Scholar
• Speck RF, Esser U, Penn ML, Eckstein DA, Pulliam L, Chan SY, Goldsmith MA (1999). A trans-receptor mechanism for infection of CD4-negative cells by human immuno-deficiency virus type 1. Curr Biol 9: 547–550.
   PubMed Web of Science ®Google Scholar
• Squinto SP, Mondal D, Block AL, Prakash O (1990). Morphine-induced transactivation of HIV-1 LTR in hu-man neuroblastoma cells. AIDS Res Hum Retroviruses 6: 1163–1168.
   PubMed Web of Science ®Google Scholar
• Stewart JL, Meeker JE (1997). Fetal and infant deaths asso-ciated with maternal methamphetamine abuse. J Anal Toxicol 21: 515–517.
   PubMed Web of Science ®Google Scholar
• Vahlenkamp TW, de Ronde A, Schuurman NN, van Vliet AL, van Drunen J, Horzinek MC, Egberink HF (1999). Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of fe-line immunodeficiency virus. J Gen Virol 80: 2639–2646.
   Google Scholar
• Verschoor EJ, Boven LA, Blaak H, van Vliet AL, Horzinek MC, de Ronde A (1995). A single mu-tation within the V3 envelope neutralization do-main of feline immunodeficiency virus determines its tropism for CRFK cells. J Virol 69: 4752–4757.
   PubMed Web of Science ®Google Scholar
• Willett BJ, Hosie MJ (1999). The role of the chemokine receptor CXCR4 in infection with feline immunodefi-ciency virus. Mo/ Membr Biol 16: 67–72.
   PubMed Web of Science ®Google Scholar
• World Health Organization (2000). Report on global surveillance of epidemic-prone infectious disease: HIV and AIDS. Geneva, Switzerland, WHO Information Office.
   Google Scholar
• Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, Major EO, Nath A, Berman JW (2000). Mechanisms of leukocyte trafficking into the CNS. J NeuroVirol 6 (Suppl 1): S82–85.
   PubMedGoogle Scholar
• Yu N, Billaud JN, Phillips TR (1998). Effects of feline im-munodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous sys-tem diseases. Proc Natl Acad Sci USA 95: 2624–2629.
   Google Scholar